Advertisement
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal
This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more
- Advicenne Appoints Peter Meeus as CEO (2021-01-07)
Advicenne (Paris:ADVIC) (BSE:ADVIC) (Euronext: ADVIC) today announced the appointment of Peter Meeus as Chief Executive Officer of Advicenne, effective February 15, 2021 . Dr. André Ulmann, who has been serving as interim CEO, will assume the position of Chief Medi... - BioGeneration Ventures BGV IV Fund Closes at €140m (2021-01-07)
> BGV now one of the largest biotech investors in early stage ventures and company creation in Europe > BGV IV includes new investors Eli Lilly and Company and Novo Holdings, joining existing investors Bristol Myers Squibb, European Investment Fund, Industriens ... - EC Authorizes COVID-19 Vaccine Moderna in Europe (2021-01-06)
> Authorization follows European Medicines Agency recommendation of COVID-19 Vaccine Moderna > European Commission has secured 160 million doses; first deliveries to countries will begin next week Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pionee... - Faron to Present at H.C. Wainwright BioConnect Conference (2021-01-04)
Faron Pharmaceuticals Ltd ("Faron") (LON: FARN), the clinical stage biopharmaceutical company, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron Pharmaceuticals, will present in a pre-recorded presentation at the virtual H.C. Wainwright Bio... - Aprea: Phase 3 of Eprenetapopt in MDS Misses Endpoint (2020-12-28)
> The trial failed to meet its primary endpoint of complete remission (CR) rate > CR rate was 53% higher in eprenetapopt with AZA arm compared to AZA alone, but did not reach statistical significance Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceuti... - Pfizer & BioNTech: EU Approves Covid-19 Vaccine Comirnaty (2020-12-21)
> COMIRNATY® (also known as BNT162b2) receives conditional marketing authorization from the European Commission; this milestone represents a global joint effort to advance the first authorized mRNA vaccine > Pfizer and BioNTech are ready to immediately ship init... - BioNTech & Pfizer:Positive CHMP Opinion for Covid-19 Vaccine (2020-12-21)
> European Commission decision on conditional marketing authorization expected imminently > Positive CHMP opinion follows several emergency use authorizations worldwide; committee reviewed totality of scientific evidence, including Phase 3 efficacy and safety da... - NuCana plc Appoints Andrew Kay as Board Chairman (2020-12-21)
> Pharmaceutical Executive Brings a Wealth of Experience to NuCana’s Board of Directors > Previously Served as CEO of Algeta, Chairman of Wilson Therapeutics and Chairman of KaNDy Therapeutics NuCana plc, a clinical-stage biopharmaceutical company focused o... - Sobi Appoints Duane Barnes as Head of North America (2020-12-21)
Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has appointed Duane Barnes as the new Head of Sobi in North America. "Sobi in North America has gone through significant change over the past few years and has exciting launches both underway and coming up in... - Novo Holdings Creates Bleeding Disorder Company Hemab ApS (2020-12-14)
> Funded through Novo Seeds’ company creation and building efforts > Focus on rare underserved bleeding disorders with large unmet need > Brings together a strong industrial R&D team with deep expertise in hemophilia and clinically validated technologies from...
Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!
[LSS] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!
» Start here with the latest News!Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top